시장보고서
상품코드
1384827

세계의 고압산소요법 기기 시장 규모, 점유율, 산업 동향 분석 리포트 : 용도별, 제품별, 지역별 전망과 예측(2023-2030년)

Global Hyperbaric Oxygen Therapy Devices Market Size, Share & Industry Trends Analysis Report By Application, By Product, By Regional Outlook and Forecast, 2023 - 2030

발행일: | 리서치사: KBV Research | 페이지 정보: 영문 277 Pages | 배송안내 : 즉시배송

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

고압산소요법 기기 시장 규모는 예측 기간 중 CAGR 5.1%로 성장하며, 2030년에는 47억 달러에 달할 것으로 예측됩니다. 2022년 시장 규모는 1,13,114대로, 성장률은 4.9%에 달하고 있습니다.(2019-2022년)

그러나, 압력 변화로 인한 상처는 압력 변화로 인한 상처를 의미하며, HBOT 중 압력 변화는 귀, 부비동, 폐에 영향을 미칠 수 있습니다. 환자는 귀 통증, 부비동 혼잡, 폐 손상을 경험할 수 있습니다. 이러한 위험을 줄이기 위해 환자를 신중하게 선별하고 안전 조치를 취하지만, 일부 환자는 압력 외상 가능성 때문에 HBOT를 받지 않으려는 사람도 있습니다. 고농도 산소에 장시간 노출되면 산소 중독을 일으켜 폐와 중추신경계 문제를 유발할 수 있으며, HBOT 세션은 산소 중독의 위험을 최소화하기 위해 주의 깊게 모니터링됩니다. 경우에 따라 건강 보험이 HBOT를 보장하지 않을 수 있으며, 자기 부담금을 지불할 수 없는 환자들은 HBOT를 이용하기 어렵고, HBOT와 그 위험에 대한 잘못된 정보와 오해가 잠재적인 환자들의 발목을 잡을 수도 있습니다. 위의 측면은 시장 성장에 방해가 될 수 있습니다.

COVID-19는 고압산소치료기 시장에 부정적인 영향을 미쳤습니다. 다른 많은 산업과 마찬가지로 전염병의 초기 단계에서 HBOT 장비를 포함한 의료기기의 제조 및 공급망은 혼란을 겪었습니다. 잠금, 이동 제한 및 공급망 중단은 이러한 장비의 생산 및 유통에 영향을 미쳤습니다. 이로 인해 당장 생명을 위협하는 것으로 간주되지 않는 증상에 대한 HBOT 기기의 사용이 일시적으로 감소했으며, COVID-19 관련 합병증 치료에 대한 HBOT의 효능을 탐구하는 임상시험과 연구가 시작되었습니다. 그러나 시장은 팬데믹 이후 빠르게 회복되어 향후 수년간 크게 확대될 것으로 예상됩니다.

용도별 전망

용도에 따라 시장은 상처 치유, 감압증, 감염 치료, 가스 색전증 및 기타로 세분화됩니다. 감압증 분야는 2022년 시장에서 큰 매출 점유율을 차지할 것으로 예상되며, HBOT는 '잠수병'으로도 알려진 감압증(DCS)에 대한 매우 효과적인 치료법입니다. 감압증은 스쿠버 다이버나 수중 작업자가 고압 환경(수중 등)에서 저압 환경(수면)으로 너무 빠르게 상승할 때 발생합니다. 이 급격한 압력 변화로 인해 체내 조직과 혈류에 질소 기포가 발생하여 관절통, 흉통, 호흡곤란, 신경증상 등 다양한 증상을 유발합니다.

제품 전망

제품별로는 모노플레이스, 멀티플레이스, 국소형 등으로 구분되며, 2022년에는 모노플레이스 부문이 가장 큰 매출 점유율을 차지할 것으로 예상됩니다. 모노플레이스 시스템은 사용이 편리하고 병원에 최소한의 가스 공급이 필요하기 때문에 채택률이 높고 상업적 활용도가 높아 시장 점유율 확대의 주요 요인으로 작용하고 있습니다. 가장 널리 사용되는 고압챔버는 ETC의 BARA-MED, BARA-MEDXD, BARA-MED Select, Pan-America Hyperbarics, Inc.의 PAH-S1-3800 고압챔버와 PAH-S1 고압챔버가 있습니다.

지역별 전망

지역별로는 북미, 유럽, 아시아태평양, LAMEA로 시장을 분석했으며, 2022년에는 북미가 시장에서 가장 높은 매출 점유율을 기록할 것으로 예상됩니다. 이 지역의 인구 증가로 인해 고압 산소 치료에 대한 수요와 상처 회복 치료의 필요성이 증가하고 있습니다. 2023년 2월, 미국 마우이 메모리얼 메디컬 센터는 치유되지 않는 상처에 대한 종합적인 접근 방식을 제공하는 고압 산소 치료를 갖춘 상처 치료 클리닉을 개설했습니다.를 개설했습니다.

목차

제1장 시장 범위와 조사 방법

  • 시장의 정의
  • 목적
  • 시장 범위
  • 세분화
  • 조사 방법

제2장 시장의 개요

  • 주요 하이라이트

제3장 시장 개요

  • 서론
    • 개요
      • 시장 구성과 시나리오
  • 시장에 영향을 미치는 주요 요인
    • 시장 촉진요인
    • 시장 억제요인
  • Porter's Five Forces 분석

제4장 세계의 고압산소요법 기기 시장 : 용도별

  • 세계의 창상 치유 시장 : 지역별
  • 세계의 감압증 시장 : 지역별
  • 세계의 감염증 치료 시장 : 지역별
  • 세계의 가스 색전증 시장 : 지역별
  • 세계의 기타 시장 : 지역별

제5장 세계의 고압산소요법 기기 시장 : 제품별

  • 세계의 모노플레이스 시장 : 지역별
  • 세계 멀티플레이스 시장 : 지역별
  • 세계의 국부 시장 : 지역별

제6장 세계의 고압산소요법 기기 시장 : 지역별

  • 북미 시장
  • 유럽 시장
  • 아시아태평양 시장
  • 라틴아메리카·중동 및 아프리카 시장

제7장 기업 개요

  • Fink Engineering Pty Ltd
  • Environmental Tectonics Corporation
  • HAUX-LIFE-SUPPORT GmbH
  • Gulf Coast Hyperbarics, Inc
  • HearMEC Co, Ltd.
  • Hyperbaric SAC
  • Sechrist Industries, Inc
  • SOS Group GBR Ltd
  • Perry Baromedical Corporation
  • SMP Ltd

제8장 시장의 성공 필수 조건

KSA 23.12.04

The Global Hyperbaric Oxygen Therapy Devices Market size is expected to reach $4.7 billion by 2030, rising at a market growth of 5.1% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,13,114 units, experiencing a growth of 4.9% (2019-2022).

HBOT can be used as an adjunctive treatment for certain infections, particularly those caused by anaerobic bacteria or those that benefit from increased oxygen levels to enhance the body's natural defense mechanisms. Consequently, the infection treatment segment experienced $351.9 million revenue in the market in 2022. Anaerobic bacteria are microorganisms that thrive in low-oxygen environments. HBOT exposes the body to high oxygen concentrations, creating an oxygen-rich environment inhospitable to many anaerobic pathogens. This inhibits the growth and replication of these bacteria. HBOT is administered in specialized hyperbaric chambers under the supervision of trained medical personnel. Some of the factors impacting the market are growing demand for next generation multiplace chambers, rising prevalence of chronic diseases and side effects and complications associated with HBOT.

Next generation multiplace chambers are designed with a focus on patient comfort. They often offer more spacious interiors with better seating arrangements, lighting, and entertainment options. Enhanced comfort can encourage patients to undergo longer and more effective HBOT sessions. Multiplace chambers can accommodate multiple patients simultaneously, making them a more cost-effective and efficient option for healthcare facilities. This increased capacity can reduce waiting times for patients and improve accessibility to HBOT therapy. The rising number of chronic diseases has significantly driven the hyperbaric oxygen therapy devices market growth. Chronic diseases are long-term medical conditions that often require ongoing treatment and care. HBOT has proven effective in managing and treating various chronic diseases and associated complications, increasing adoption. Diabetes is an ordinary chronic disease that can lead to difficulties such as diabetic foot ulcers. HBOT is a recognized treatment for diabetic foot ulcers, as it promotes wound healing and reduces the risk of amputation. Therefore, as healthcare providers and patients recognize the advantages of HBOT in managing and improving the quality of life for those with chronic diseases, the market for hyperbaric oxygen therapy devices is expected to continue to rise.

However, Barotrauma refers to wounds caused by changes in pressure. During HBOT, changes in pressure can affect the ears, sinuses, and lungs. Patients may experience ear pain, sinus congestion, or lung injuries. In order to mitigate this risk, patients are carefully screened, and safety measures are put in place, but the potential for barotrauma can deter some individuals from seeking HBOT. Prolonged exposure to high oxygen levels can lead to oxygen toxicity, which can cause lung and central nervous system problems. HBOT sessions are carefully monitored to minimize the risk of oxygen toxicity. In some circumstances, health insurance may not cover HBOT, making it less accessible to patients who cannot afford the out-of-pocket costs. Misinformation or misconceptions about HBOT and its risks can deter potential patients. The abovementioned aspects will hamper the market growth.

COVID-19 had a negative impact on the hyperbaric oxygen therapy devices market. Like many other industries, the manufacturing and supply chain for medical devices, including HBOT devices, were disrupted during the early stages of the pandemic. Lockdowns, restrictions on movement, and supply chain interruptions affected the production and distribution of these devices. This led to a temporary decline in the use of HBOT devices for conditions that were not considered immediately life-threatening. Clinical trials and studies exploring the efficacy of HBOT in treating COVID-19-related complications were initiated. However, the market witnessed a speedy recovery after the pandemic and will expand significantly in the coming years.

Application Outlook

Based on application, the market is fragmented into wound healing, decompression sickness, infection treatment, gas embolism, and others. The decompression sickness segment garnered a significant revenue share in the market in 2022. HBOT is a highly effective treatment for decompression sickness (DCS), also known as "the bends." DCS occurs when a scuba diver or underwater worker ascends too quickly from a high-pressure environment (such as underwater) to a lower-pressure environment (the surface). This rapid change in pressure can cause nitrogen bubbles in the body's tissues and bloodstream, leading to various symptoms, including joint pain, chest pain, breathing difficulties, and neurological symptoms.

Product Outlook

On the basis of product, the market is segmented into monoplace, multiplace, and topical. In 2022, the monoplace segment dominated the market with the maximum revenue share. The substantial adoption rate and commercial accessibility of monoplace systems, due to their user-friendliness and minimal need for hospital gas supply, are significant contributors to its larger market share. The most popular hyperbaric chambers are BARA-MED, BARA-MEDXD, and BARA-MED Select by ETC; PAH-S1-3800 Hyperbaric Chamber and PAH-S1 Hyperbaric Chamber by Pan-America Hyperbarics, Inc.

Regional Outlook

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region registered the highest revenue share in the market. The region's growing population has fueled the region's demand for hyperbaric oxygen therapy and the need for wound recovery treatment. Consumers' increasing disposable income has prompted them to seek technologically advanced medical treatments and therapies. In February of 2023, the Maui Memorial Medical Center in the United States opened a wound care clinic with hyperbaric oxygen therapy, which provides a comprehensive approach to non-healing wounds.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fink Engineering Pty Ltd, Environmental Tectonics Corporation, HAUX-LIFE-SUPPORT GmbH, Gulf Coast Hyperbarics, Inc., HearMEC Co., Ltd., Hyperbaric SAC, Sechrist Industries, Inc, SOS Group GBR Ltd., Perry Baromedical Corporation and SMP Ltd.

Scope of the Study

Market Segments covered in the Report:

By Application (Volume, Unit, USD Million, 2019-30)

  • Wound Healing
  • Decompression Sickness
  • Infection Treatment
  • Gas Embolism
  • Others

By Product (Volume, Unit, USD Million, 2019-30)

  • Monoplace
  • Multiplace
  • Topical

By Geography (Volume, Unit, USD Million, 2019-30)

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Fink Engineering Pty Ltd
  • Environmental Tectonics Corporation
  • HAUX-LIFE-SUPPORT GmbH
  • Gulf Coast Hyperbarics, Inc.
  • HearMEC Co., Ltd.
  • Hyperbaric SAC
  • Sechrist Industries, Inc
  • SOS Group GBR Ltd
  • Perry Baromedical Corporation
  • SMP Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Hyperbaric Oxygen Therapy Devices Market, by Application
    • 1.4.2 Global Hyperbaric Oxygen Therapy Devices Market, by Product
    • 1.4.3 Global Hyperbaric Oxygen Therapy Devices Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market At a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter's Five Forces Analysis

Chapter 4. Global Hyperbaric Oxygen Therapy Devices Market, by Application

  • 4.1 Global Wound Healing Market, by Region
  • 4.2 Global Decompression Sickness Market, by Region
  • 4.3 Global Infection Treatment Market, by Region
  • 4.4 Global Gas Embolism Market, by Region
  • 4.5 Global Others Market, by Region

Chapter 5. Global Hyperbaric Oxygen Therapy Devices Market, by Product

  • 5.1 Global Monoplace Market, by Region
  • 5.2 Global Multiplace Market, by Region
  • 5.3 Global Topical Market, by Region

Chapter 6. Global Hyperbaric Oxygen Therapy Devices Market, by Region

  • 6.1 North America Hyperbaric Oxygen Therapy Devices Market
    • 6.1.1 North America Hyperbaric Oxygen Therapy Devices Market, by Application
      • 6.1.1.1 North America Wound Healing Market, by Country
      • 6.1.1.2 North America Decompression Sickness Market, by Country
      • 6.1.1.3 North America Infection Treatment Market, by Country
      • 6.1.1.4 North America Gas Embolism Market, by Country
      • 6.1.1.5 North America Others Market, by Country
    • 6.1.2 North America Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.1.2.1 North America Monoplace Market, by Country
      • 6.1.2.2 North America Multiplace Market, by Country
      • 6.1.2.3 North America Topical Market, by Country
    • 6.1.3 North America Hyperbaric Oxygen Therapy Devices Market, by Country
      • 6.1.3.1 US Hyperbaric Oxygen Therapy Devices Market
        • 6.1.3.1.1 US Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.1.3.1.2 US Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.1.3.2 Canada Hyperbaric Oxygen Therapy Devices Market
        • 6.1.3.2.1 Canada Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.1.3.2.2 Canada Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.1.3.3 Mexico Hyperbaric Oxygen Therapy Devices Market
        • 6.1.3.3.1 Mexico Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.1.3.3.2 Mexico Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.1.3.4 Rest of North America Hyperbaric Oxygen Therapy Devices Market
        • 6.1.3.4.1 Rest of North America Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.1.3.4.2 Rest of North America Hyperbaric Oxygen Therapy Devices Market, by Product
  • 6.2 Europe Hyperbaric Oxygen Therapy Devices Market
    • 6.2.1 Europe Hyperbaric Oxygen Therapy Devices Market, by Application
      • 6.2.1.1 Europe Wound Healing Market, by Country
      • 6.2.1.2 Europe Decompression Sickness Market, by Country
      • 6.2.1.3 Europe Infection Treatment Market, by Country
      • 6.2.1.4 Europe Gas Embolism Market, by Country
      • 6.2.1.5 Europe Others Market, by Country
    • 6.2.2 Europe Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.2.2.1 Europe Monoplace Market, by Country
      • 6.2.2.2 Europe Multiplace Market, by Country
      • 6.2.2.3 Europe Topical Market, by Country
    • 6.2.3 Europe Hyperbaric Oxygen Therapy Devices Market, by Country
      • 6.2.3.1 Germany Hyperbaric Oxygen Therapy Devices Market
        • 6.2.3.1.1 Germany Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.2.3.1.2 Germany Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.2.3.2 UK Hyperbaric Oxygen Therapy Devices Market
        • 6.2.3.2.1 UK Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.2.3.2.2 UK Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.2.3.3 France Hyperbaric Oxygen Therapy Devices Market
        • 6.2.3.3.1 France Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.2.3.3.2 France Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.2.3.4 Russia Hyperbaric Oxygen Therapy Devices Market
        • 6.2.3.4.1 Russia Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.2.3.4.2 Russia Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.2.3.5 Spain Hyperbaric Oxygen Therapy Devices Market
        • 6.2.3.5.1 Spain Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.2.3.5.2 Spain Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.2.3.6 Italy Hyperbaric Oxygen Therapy Devices Market
        • 6.2.3.6.1 Italy Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.2.3.6.2 Italy Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.2.3.7 Rest of Europe Hyperbaric Oxygen Therapy Devices Market
        • 6.2.3.7.1 Rest of Europe Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.2.3.7.2 Rest of Europe Hyperbaric Oxygen Therapy Devices Market, by Product
  • 6.3 Asia Pacific Hyperbaric Oxygen Therapy Devices Market
    • 6.3.1 Asia Pacific Hyperbaric Oxygen Therapy Devices Market, by Application
      • 6.3.1.1 Asia Pacific Wound Healing Market, by Country
      • 6.3.1.2 Asia Pacific Decompression Sickness Market, by Country
      • 6.3.1.3 Asia Pacific Infection Treatment Market, by Country
      • 6.3.1.4 Asia Pacific Gas Embolism Market, by Country
      • 6.3.1.5 Asia Pacific Others Market, by Country
    • 6.3.2 Asia Pacific Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.3.2.1 Asia Pacific Monoplace Market, by Country
      • 6.3.2.2 Asia Pacific Multiplace Market, by Country
      • 6.3.2.3 Asia Pacific Topical Market, by Country
    • 6.3.3 Asia Pacific Hyperbaric Oxygen Therapy Devices Market, by Country
      • 6.3.3.1 China Hyperbaric Oxygen Therapy Devices Market
        • 6.3.3.1.1 China Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.3.3.1.2 China Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.3.3.2 Japan Hyperbaric Oxygen Therapy Devices Market
        • 6.3.3.2.1 Japan Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.3.3.2.2 Japan Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.3.3.3 India Hyperbaric Oxygen Therapy Devices Market
        • 6.3.3.3.1 India Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.3.3.3.2 India Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.3.3.4 South Korea Hyperbaric Oxygen Therapy Devices Market
        • 6.3.3.4.1 South Korea Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.3.3.4.2 South Korea Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.3.3.5 Singapore Hyperbaric Oxygen Therapy Devices Market
        • 6.3.3.5.1 Singapore Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.3.3.5.2 Singapore Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.3.3.6 Malaysia Hyperbaric Oxygen Therapy Devices Market
        • 6.3.3.6.1 Malaysia Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.3.3.6.2 Malaysia Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.3.3.7 Rest of Asia Pacific Hyperbaric Oxygen Therapy Devices Market
        • 6.3.3.7.1 Rest of Asia Pacific Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.3.3.7.2 Rest of Asia Pacific Hyperbaric Oxygen Therapy Devices Market, by Product
  • 6.4 LAMEA Hyperbaric Oxygen Therapy Devices Market
    • 6.4.1 LAMEA Hyperbaric Oxygen Therapy Devices Market, by Application
      • 6.4.1.1 LAMEA Wound Healing Market, by Country
      • 6.4.1.2 LAMEA Decompression Sickness Market, by Country
      • 6.4.1.3 LAMEA Infection Treatment Market, by Country
      • 6.4.1.4 LAMEA Gas Embolism Market, by Country
      • 6.4.1.5 LAMEA Others Market, by Country
    • 6.4.2 LAMEA Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.4.2.1 LAMEA Monoplace Market, by Country
      • 6.4.2.2 LAMEA Multiplace Market, by Country
      • 6.4.2.3 LAMEA Topical Market, by Country
    • 6.4.3 LAMEA Hyperbaric Oxygen Therapy Devices Market, by Country
      • 6.4.3.1 Brazil Hyperbaric Oxygen Therapy Devices Market
        • 6.4.3.1.1 Brazil Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.4.3.1.2 Brazil Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.4.3.2 Argentina Hyperbaric Oxygen Therapy Devices Market
        • 6.4.3.2.1 Argentina Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.4.3.2.2 Argentina Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.4.3.3 UAE Hyperbaric Oxygen Therapy Devices Market
        • 6.4.3.3.1 UAE Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.4.3.3.2 UAE Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.4.3.4 Saudi Arabia Hyperbaric Oxygen Therapy Devices Market
        • 6.4.3.4.1 Saudi Arabia Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.4.3.4.2 Saudi Arabia Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.4.3.5 South Africa Hyperbaric Oxygen Therapy Devices Market
        • 6.4.3.5.1 South Africa Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.4.3.5.2 South Africa Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.4.3.6 Nigeria Hyperbaric Oxygen Therapy Devices Market
        • 6.4.3.6.1 Nigeria Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.4.3.6.2 Nigeria Hyperbaric Oxygen Therapy Devices Market, by Product
      • 6.4.3.7 Rest of LAMEA Hyperbaric Oxygen Therapy Devices Market
        • 6.4.3.7.1 Rest of LAMEA Hyperbaric Oxygen Therapy Devices Market, by Application
        • 6.4.3.7.2 Rest of LAMEA Hyperbaric Oxygen Therapy Devices Market, by Product

Chapter 7. Company Profiles

  • 7.1 Fink Engineering Pty Ltd.
    • 7.1.1 Company Overview
    • 7.1.2 SWOT Analysis
  • 7.2 Environmental Tectonics Corporation
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental and Regional Analysis
    • 7.2.4 Research & Development Expenses
    • 7.2.5 SWOT Analysis
  • 7.3 HAUX-LIFE-SUPPORT GmbH
    • 7.3.1 Company Overview
    • 7.3.2 SWOT Analysis
  • 7.4 Gulf Coast Hyperbarics, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 SWOT Analysis
  • 7.5 HearMEC Co., Ltd.
    • 7.5.1 Company Overview
    • 7.5.2 SWOT Analysis
  • 7.6 Hyperbaric SAC
    • 7.6.1 Company Overview
    • 7.6.2 SWOT Analysis
  • 7.7 Sechrist Industries, Inc.
    • 7.7.1 Company Overview
    • 7.7.2 SWOT Analysis
  • 7.8 SOS Group GBR Ltd
    • 7.8.1 Company Overview
    • 7.8.2 SWOT Analysis
  • 7.9 Perry Baromedical Corporation
    • 7.9.1 Company Overview
    • 7.9.2 SWOT Analysis
  • 7.10. SMP Ltd.
    • 7.10.1 Company Overview
    • 7.10.2 Recent strategies and developments:
      • 7.10.2.1 Partnerships, Collaborations, and Agreements:
    • 7.10.3 SWOT Analysis

Chapter 8. Winning Imperatives of Hyperbaric Oxygen Therapy Devices Market

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제